IRBs To Be Subject Of House Hearing After “Congressional Sting Operation”
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO of Coast Institutional Review Board, which approved an imaginary study, will testify before Rep. Stupak’s subcommittee.
You may also be interested in...
IRB Oversight: HHS’ Registration Practices, Firms Conduct To Face Greater Scrutiny
Hearing in House may boost prospects of legislation that would impose new requirements on the initial approval of clinical trials.
IRB Oversight: HHS’ Registration Practices, Firms Conduct To Face Greater Scrutiny
Hearing in House may boost prospects of legislation that would impose new requirements on the initial approval of clinical trials.
House Energy & Commerce To Continue Foraging Through Vytorin Data
The House Energy & Commerce Committee intends to keep hounding Merck and Schering-Plough for data and internal communications on how the company handled the release of information from three trials on Vytorin (simvastatin/ezetimibe)